S&P 500 Financials Sector SEC Filings — January 07, 2026

08-01-2026

Curis Inc filed a Form 8-K on January 8, 2026 (AccNo: 0001108205-26-000002, Size: 1 MB), reporting events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no transaction values, share counts, financial metrics, named parties, or other quantitative details disclosed in the provided information.

08-01-2026

GENELUX Corp filed a Form 8-K on January 08, 2026 (AccNo: 0001493152-26-000989, Size: 617 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific other events or financial statements/exhibits are disclosed in the provided filing summary. This is a multi-item filing with sector not specified.

08-01-2026

T-REX Acquisition Corp. filed an 8-K on 2026-01-08 (AccNo: 0001477932-26-000088, Size: 136 KB) disclosing a Merger/Acquisition under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on deal structure, parties, valuation, or financial metrics are provided in the filing summary. Sector is not specified.

08-01-2026

Terreno Realty Corp filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-006930), reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with financial statements and exhibits under Item 9.01. No specific details on the transaction, parties, dollar values, or other quantitative metrics are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of a material event.

08-01-2026

FARADAY FUTURE INTELLIGENT ELECTRIC INC. filed a Form 8-K on January 08, 2026 (AccNo: 0001213900-26-002315, Size: 281 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the financial statements/exhibits are disclosed in the provided filing summary. This is a multi-item general filing from the US SEC.

08-01-2026

Enpro Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001140361-26-000570, Size: 139 KB) disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual names, reasons for change, or quantitative data are provided in the summary. Sector is not specified.

08-01-2026

ACRO BIOMEDICAL CO., LTD. filed a Form 8-K on January 08, 2026, reporting changes in its certifying accountant under Item 4.01 and including financial statements and exhibits under Item 9.01. No specific details on the accountant change, financial metrics, transaction values, or other numerical data are disclosed in the filing summary. This is a multi-item mandatory disclosure with file size of 138 KB and AccNo 0001640334-26-000053.

08-01-2026

SmartStop Self Storage REIT, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-006699, Size: 146 KB) reporting under Item 7.01 Regulation FD Disclosure. No details on the content of the disclosure, transaction values, financial metrics, or other specifics are provided in the filing summary. Sector is not specified.

08-01-2026

Crown Electrokinetics Corp. filed an 8-K on 2026-01-08 (AccNo: 0001213900-26-002308, Size: 231 KB) disclosing Item 1.01 Entry into a Material Definitive Agreement and Item 2.01 Completion of Acquisition or Disposition of Assets. Item 9.01 provides Financial Statements and Exhibits. No specific details on deal structure, parties, valuation, consideration, or financial metrics are disclosed.

08-01-2026

Compass, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001563190-26-000009, Size: 190 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or other specifics are disclosed in the provided filing summary. This is a multi-item general filing from the US SEC with sector not specified.

08-01-2026

Neuphoria Therapeutics Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001213900-26-002245, size 293 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 1.02 termination of a material definitive agreement, with financial statements and exhibits under Item 9.01. No details on the agreements, parties, values, or impacts are disclosed. This is a multi-item mandatory filing as a material event.

08-01-2026

Catheter Precision, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001437749-26-000839, Size: 287 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, parties, or other terms are disclosed.

08-01-2026

Kinsale Capital Group, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001669162-26-000004, Size: 4 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or other numerical data are explicitly stated. Sector is not specified.

08-01-2026

NEWS CORP filed a Form 8-K on January 08, 2026 (AccNo: 0001564708-26-000005, Size: 400 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific other event, financial statements, exhibits, transaction values, or other quantitative metrics are disclosed in the provided filing summary. Sector is not specified.

08-01-2026

Brookfield Asset Management Ltd. filed a Form 8-K on January 08, 2026 (AccNo: 0001171843-26-000130, Size: 216 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, or exhibits are provided in the filing summary. Sector not specified.

08-01-2026

Global Net Lease, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001104659-26-001919, Size: 292 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the content of the Regulation FD disclosure or specific exhibits are provided. Sector not specified.

08-01-2026

Vanda Pharmaceuticals Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001628280-26-001273, Size: 238 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.

08-01-2026

RPM International Inc./DE/ filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-006976, Size: 472 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a financial results disclosure with no specific revenue, earnings, or other metrics detailed in the provided information. Sector is not specified.

08-01-2026

Climb Bio, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-006994, Size: 203 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or other specific content from the filing is disclosed in the provided summary. All quantitative data and impacts are NOT_DISCLOSED.

08-01-2026

TELEFLEX INC filed a Form 8-K on January 08, 2026 (AccNo: 0000096943-26-000003, Size: 192 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). The filing also covers Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, reason, financial metrics, or quantitative data are provided.

08-01-2026

Amylyx Pharmaceuticals, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-006991, Size: 20 MB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the core events, transactions, financial impacts, or exhibits are disclosed in the provided filing summary. All quantitative financial data, named entities beyond the filer, and event specifics are NOT_DISCLOSED.

08-01-2026

TD SYNNEX CORP filed a Form 8-K on January 8, 2026 (AccNo: 0001628280-26-001271, Size: 1 MB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This appears to be a voluntary disclosure of financial results. No specific revenue, earnings, transaction values, or other quantitative metrics are mentioned.

08-01-2026

Indivior PLC filed a General Filing (likely Form 8-K) on January 08, 2026 (AccNo: 0001193125-26-006993), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the core event, transaction, or financial impacts provided in the filing summary. All quantitative data and named entities beyond the filer are NOT_DISCLOSED.

08-01-2026

Jasper Therapeutics, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001213900-26-002329, Size: 36 MB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.

08-01-2026

Amarin Corp PLC/UK filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-006992, Size: 333 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a financial results disclosure from the US market. No quantitative financial metrics, transaction values, or specific details are disclosed in the provided filing summary.

08-01-2026

NEOGEN CORP filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-006990, Size: 904 KB) reporting financial results under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a financial results announcement from the US SEC. No specific financial metrics, transaction values, or other quantitative details are disclosed in the provided filing summary.

08-01-2026

Xeris Biopharma Holdings, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001867096-26-000004, Size: 222 KB) reporting under Item 2.02 for Results of Operations and Financial Condition. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. This appears to be a voluntary disclosure of financial results.

08-01-2026

Soho House & Co Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001140361-26-000611, Size: 170 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, financial impacts, or other material information are disclosed in the provided filing summary. Sector is not specified.

08-01-2026

Cullinan Therapeutics, Inc. filed an 8-K on January 8, 2026 (AccNo: 0001193125-26-006998, Size: 225 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary financial results disclosure with no specific financial metrics, transaction details, or quantitative data disclosed in the provided summary.

08-01-2026

Simply Good Foods Co filed a Form 8-K on January 8, 2026 (AccNo: 0001702744-26-000004, size 1 MB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, transaction values, guidance, or other quantitative financial metrics are disclosed in the provided filing summary. This appears to be a standard voluntary disclosure of financial results.

08-01-2026

V F CORP filed a Form 8-K on January 08, 2026 (AccNo: 0000103379-26-000004, Size: 213 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, or exhibits are provided. Sector not specified.

08-01-2026

Invivyd, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-006997), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific financial metrics, transaction details, or numerical values disclosed in the provided summary. Sector is not specified.

08-01-2026

STANDARD BIOTOOLS INC. filed an 8-K on January 08, 2026 (AccNo: 0001193125-26-006996, Size: 294 KB) reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific financial metrics, transaction values, or other quantitative details are disclosed in the provided filing summary. Sector is not specified.

08-01-2026

Opus Genetics, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001140361-26-000615, Size: 188 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event, transaction details, financial metrics, or quantitative data are explicitly stated in the provided filing summary. All specific numbers such as transaction values, share counts, or percentages are NOT_DISCLOSED.

08-01-2026

Entrada Therapeutics, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001689375-26-000003, Size: 212 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 8.01 (Other Events). This is a multi-item filing related to financial results in the US market. No specific financial metrics, transaction details, or numerical values are disclosed in the provided filing summary.

08-01-2026

Lindsay Corp filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-007004, size 10 MB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure from the US market, sector not specified. No specific revenue, earnings, transaction values, or other quantitative financial metrics are mentioned.

08-01-2026

AMERICAN ELECTRIC POWER CO INC filed a Form 8-K on January 08, 2026, reporting under Item 8.01 Other Events. Accession Number: 0000004904-26-000003. File size: 184 KB; no specific details on the event or transaction disclosed.

08-01-2026

Soluna Holdings, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001493152-26-000891, Size: 333 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosure content, transactions, financial metrics, or named entities beyond the filer are provided. All quantitative data such as transaction values, share counts, or percentages is NOT_DISCLOSED.

08-01-2026

Acrivon Therapeutics, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-007007, Size: 331 KB), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction values, or other quantitative details are disclosed in the provided filing summary.

08-01-2026

Context Therapeutics Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001628280-26-001275, Size: 5 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or other quantitative data are specified in the filing summary. Sector is not specified.

08-01-2026

Acuity Inc. (DE) filed a Form 8-K on January 8, 2026 (AccNo: 0001144215-26-000012, Size: 441 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This discloses financial results as a standard earnings-related 8-K. No specific revenue, earnings, transaction values, or other quantitative financial metrics are mentioned.

08-01-2026

Bone Biologics Corp filed a Form 8-K on January 08, 2026 (AccNo: 0001493152-26-000896, Size: 287 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or quantitative data are explicitly stated in the provided filing summary. This appears to be a multi-item voluntary disclosure with no specified timing relative to events.

08-01-2026

Xencor Inc filed a Form 8-K on January 8, 2026 (AccNo: 0001326732-26-000002, Size: 191 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. Sector is not specified.

08-01-2026

Collegium Pharmaceutical, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001104659-26-001953, Size: 9 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or other specific content are disclosed in the provided filing summary. Sector is not specified.

08-01-2026

Transcat Inc filed a Form 8-K on January 8, 2026 (AccNo: 0001206774-26-000020, Size: 285 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data are provided in the filing summary. Sector is not specified.

08-01-2026

Century Therapeutics, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001104659-26-001952, Size: 7 MB), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, share counts, or other numerical data disclosed in the provided summary. Sector is not specified.

08-01-2026

MEXICO FUND INC filed a Form 8-K on January 08, 2026 (AccNo: 0001654954-26-000168, Size: 199 KB), disclosing Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or quantitative data are specified in the filing summary. This appears to be a multi-item voluntary filing focused on regulatory compliance and exhibits.

08-01-2026

Spruce Biosciences, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-007038, Size: 1 MB), reporting multiple items including entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item filing with no specific transaction details, dollar values, or financial metrics disclosed in the provided summary. Sector not specified.

08-01-2026

Personalis, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007037, size 235 KB), reporting results of operations and financial condition under Item 2.02. The filing also includes financial statements and exhibits under Item 9.01. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided summary.

08-01-2026

Limitless X Holdings Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001493152-26-000895), reporting under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure with no specific transaction values, share counts, dollar amounts, or named entities beyond the filer disclosed. Sector is not specified.

08-01-2026

Beneficient filed a Form 8-K on January 8, 2026 (AccNo: 0001493152-26-000893, Size: 10 MB) as a multi-item disclosure covering Item 3.02 (Unregistered Sales of Equity Securities), Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific transaction details, dollar values, share counts, or other quantitative metrics are disclosed in the provided filing summary. This appears to be a mandatory multi-item filing related to equity transactions and corporate governance changes.

08-01-2026

Axil Brands, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001520138-26-000007, Size: 319 KB) disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, revenue, earnings, or other quantitative data are provided in the filing summary. This is a multi-item filing focused on financial results with no additional named entities or key facts extracted.

08-01-2026

GRI Bio, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001824293-26-000002, Size: 250 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. Sector not specified. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary.

08-01-2026

MoonLake Immunotherapeutics filed a Form 8-K on January 08, 2026 (AccNo: 0001213900-26-002344, Size: 250 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.

08-01-2026

Frontier Group Holdings, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007030, Size: 170 KB) disclosing an officer change under Item 5.02, alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). Specific details on the officer position, appointment/resignation, reasons, or individuals involved are NOT_DISCLOSED. No quantitative financial metrics, transaction values, or share counts are mentioned.

08-01-2026

Voyager Therapeutics, Inc. filed an 8-K on January 08, 2026 (AccNo: 0001104659-26-001955, Size: 8 MB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or quantitative data are explicitly stated in the provided filing summary. Sector is not specified.

08-01-2026

Williams Companies, Inc. filed an 8-K on January 8, 2026 (AccNo: 0001193125-26-007722, Size: 371 KB) reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. Sector not specified.

08-01-2026

Walmart Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0000104169-26-000008, Size: 258 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or timing are provided. Sector is not specified.

08-01-2026

CorMedix Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001213900-26-002350, Size: 297 KB), reporting an Officer Change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, position, reason for change, or financial metrics are disclosed in the provided filing summary. Sector not specified.

08-01-2026

Murphy Oil Corp filed a Form 8-K on January 8, 2026 (AccNo: 0000950103-26-000244, Size: 530 KB), reporting under Items 2.04 (Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Off-Balance Sheet Arrangement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure with no specific event details, transaction values, or financial metrics provided in the summary. Sector not specified.

08-01-2026

Northern Technologies International Corp filed a Form 8-K on January 8, 2026 (AccNo: 0001171843-26-000135, Size: 338 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure with no specific revenue, earnings, or other metrics detailed in the provided information. Sector is not specified.

08-01-2026

Ardelyx, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001437402-26-000003, Size: 152 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, revenue, earnings, or quantitative impacts are disclosed in the provided filing summary. This appears to be a standard financial results disclosure from the US SEC.

08-01-2026

Lightwave Logic, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001079973-26-000061, Size: 194 KB) disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are disclosed in the provided summary. Sector is not specified.

08-01-2026

Leslie's, Inc. disclosed an Item 5.02 event in an 8-K filing on January 8, 2026 (AccNo: 0001193125-26-007067, Size: 183 KB), related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or other quantitative data are provided in the filing summary. Sector is not specified.

08-01-2026

NewtekOne, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001628280-26-001282, Size: 8 MB), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, transaction values, or quantitative data are mentioned.

08-01-2026

Alaunos Therapeutics, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-007054, Size: 580 KB), reporting under Item 1.02 termination of a material definitive agreement, Item 3.03 material modifications to rights of security holders, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the events, transaction values, or financial impacts are provided in the summary. Sector is not specified.

08-01-2026

Commercial Metals Co filed an 8-K on January 8, 2026 (AccNo: 0000022444-26-000009, Size: 5 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, transaction values, or other quantitative data are mentioned.

08-01-2026

SELLAS Life Sciences Group, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001104659-26-001957, Size: 192 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure of financial results and other events from the US SEC. No specific financial metrics, transaction values, or numerical data are disclosed in the provided filing summary.

08-01-2026

Coya Therapeutics, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-007042, Size: 144 KB), reporting under Item 8.01 Other Events. No details on the specific event, transaction, financial impact, or other quantitative data are disclosed in the provided filing summary. Sector is not specified.

08-01-2026

Xilio Therapeutics, Inc. filed a Form 8-K on 2026-01-08 (AccNo: 0001193125-26-007063, size: 222 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). Event dated January 08, 2026; sector not specified. No specific details on officer position, appointment/resignation, reasons, or financial metrics provided.

08-01-2026

Astronics Corp filed an 8-K on January 8, 2026 (AccNo: 0000008063-26-000005, size: 218 KB), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. This is a financial results disclosure from the US market. No specific financial metrics, transaction values, or other quantitative details are disclosed in the provided filing summary.

08-01-2026

LPL Financial Holdings Inc. filed a Form 8-K on 2026-01-08 (AccNo: 0001193125-26-007083, Size: 166 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, position affected, reason for change, or any quantitative data are disclosed.

08-01-2026

Golub Capital BDC, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001476765-26-000003, Size: 161 KB), reporting results of operations and financial condition under Item 2.02 and financial statements and exhibits under Item 9.01. No specific financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary. This appears to be a standard financial results disclosure for a business development company.

08-01-2026

Atea Pharmaceuticals, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-007081, Size: 183 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure event from the US SEC. No specific financial metrics, transaction values, or detailed results are mentioned in the provided filing summary.

08-01-2026

Nuvve Holding Corp. disclosed an officer change event via Form 8-K filed on January 08, 2026 (AccNo: 0001836875-26-000008, Size: 203 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the key position affected, appointment or resignation status, reasons for change, named individuals, or quantitative data are explicitly stated in the provided filing summary. Sector is not specified.

08-01-2026

OFS Capital Corp filed a Form 8-K on January 08, 2026 (AccNo: 0001487918-26-000002, Size: 211 KB) under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). No details on the specific events, transactions, financial statements, or exhibits are provided in the filing summary. All quantitative data, core events, and impacts are NOT_DISCLOSED.

08-01-2026

60 Degrees Pharmaceuticals, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001213900-26-002359, Size: 17 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific core event, transaction details, or financial metrics disclosed in the provided summary. Sector is not specified.

08-01-2026

USANA Health Sciences Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0000896264-26-000002, size 176 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment or resignation status, reasons, or any quantitative data are provided. Sector is not specified.

08-01-2026

Lamb Weston Holdings, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001679273-26-000002, Size: 143 KB), reporting under Item 2.05 costs associated with exit or disposal activities. No specific details, dollar values, or financial impacts are disclosed in the provided filing summary. Sector is not specified.

08-01-2026

Tango Therapeutics, Inc. filed an 8-K on January 08, 2026 (AccNo: 0001193125-26-007086, Size: 5 MB), triggering Items 2.02 (Results of Operations and Financial Condition), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is classified as an Officer Change event. No specific details on officers, reasons for change, financial metrics, or quantitative data are disclosed in the provided filing summary.

08-01-2026

First Northwest Bancorp filed a Form 8-K on January 08, 2026 (AccNo: 0001437749-26-000851, Size: 152 KB), disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on the affected individuals, positions, reasons for change, or any quantitative data are provided in the filing summary. Sector is not specified.

08-01-2026

DANA Inc filed a Form 8-K on January 08, 2026 (AccNo: 0000950142-26-000088, size 188 KB), reporting under Item 8.01 Other Events. No details on the specific event, transaction, financial impact, or other material information are disclosed in the provided filing summary. Sector is not specified.

08-01-2026

Sky Quarry Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001096906-26-000041), reporting under Item 1.02 the termination of a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's parties, value, terms, or financial impact are disclosed. This represents a potentially negative event as it involves termination of something deemed material by the company.

08-01-2026

Main Street Capital CORP filed a Form 8-K on January 8, 2026 (AccNo: 0001396440-26-000003, Size: 238 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure from the US SEC with no specific numerical data, transaction details, or financial metrics provided in the summary. Multi-item voluntary filing typical for earnings announcements.

08-01-2026

Ondas Holdings Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001213900-26-002367, Size: 210 KB), reporting under Item 3.02 for Unregistered Sales of Equity Securities, Item 8.01 for Other Events, and Item 9.01 for Financial Statements and Exhibits. This is a multi-item mandatory filing with no specific transaction details, dollar values, share counts, or financial metrics disclosed in the provided summary. Sector is not specified.

08-01-2026

MSC INCOME FUND, INC. filed a Form 8-K on January 08, 2026 (AccNo: 0001535778-26-000008, Size: 287 KB) reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. Event type is Financial Results from US SEC; sector not specified. No numerical values, transaction details, or financial metrics are disclosed in the provided information.

08-01-2026

Signing Day Sports, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001213900-26-002392, size: 218 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event details, transaction values, financial metrics, or other specifics are disclosed in the provided filing summary. Sector is not specified.

08-01-2026

PURE CYCLE CORP filed an 8-K on January 08, 2026 (AccNo: 0001104659-26-001988, Size: 9 MB), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a financial results disclosure from the US market with sector not specified. No specific financial metrics, transaction values, or quantitative data are mentioned.

08-01-2026

COMMUNITY BANCORP /VT filed a Form 8-K on January 08, 2026 (AccNo: 0001654954-26-000181, size 152 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, financial statements, or exhibits are provided in the filing summary.

08-01-2026

Entergy Arkansas, LLC filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-007202, Size: 477 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, or exhibits are disclosed in the provided filing summary. Sector is not specified.

08-01-2026

Salarius Pharmaceuticals, Inc. filed a Form 8-K on 2026-01-08 (AccNo: 0001615219-26-000013, Size: 470 KB) reporting under Item 5.03 amendments to Articles of Incorporation or Bylaws or change in fiscal year, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the nature of amendments, events, or exhibits are provided in the filing summary. Sector not specified.

08-01-2026

SRx Health Solutions, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001493152-26-000926, size: 229 KB) under Item 3.01 reporting a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing from the US market. No financial details, transaction values, reasons for delisting, or other impacts are disclosed. Sector is not specified.

08-01-2026

Jet.AI Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001493152-26-000939, Size: 204 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event, financial statements, or exhibits are disclosed. All transaction values, financial metrics, and quantitative impacts are NOT_DISCLOSED.

08-01-2026

Apple iSports Group, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001477932-26-000095, Size: 128 KB), disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, names, reasons for change, or quantitative data are provided in the filing summary. Sector is not specified.

08-01-2026

HNI CORP filed a Form 8-K on January 8, 2026 (AccNo: 0001140361-26-000697, Size: 207 KB), reporting Item 2.05 Costs Associated with Exit or Disposal Activities, Item 2.06 Material Impairments, and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory disclosure of potentially negative events involving restructuring costs and asset impairments. No specific dollar values, transaction sizes, or quantitative financial impacts are disclosed.

08-01-2026

CuriosityStream Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001628280-26-001317, Size: 408 KB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure under Regulation FD to share material nonpublic information publicly. No specific details on the disclosure content, events, financials, or exhibits are provided.

08-01-2026

Simulations Plus, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001023459-26-000003, Size: 2 MB), disclosing financial results under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing for financial results announcement. No specific financial metrics, transaction values, or quantitative data are provided in the filing summary.

08-01-2026

Olin Corp filed a Form 8-K on January 08, 2026 (AccNo: 0000074303-26-000001, Size: 183 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, revenue, earnings, or other quantitative data are disclosed in the provided filing summary. This is a standard disclosure for financial results.

08-01-2026

WD-40 Company filed a Form 8-K on January 8, 2026 (AccNo: 0000105132-26-000006, Size: 439 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. This appears to be a standard financial results disclosure.

08-01-2026

CervoMed Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001437749-26-000883, size 162 KB), reporting under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This appears to be a multi-item, voluntary disclosure related to material non-public information shared selectively, with attached exhibits. No core event details, transaction values, financial metrics, or other specifics are provided in the filing summary.

08-01-2026

Beta Bionics, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001171843-26-000145, Size: 227 KB) reporting under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a financial results disclosure event from the US SEC. No specific financial metrics, transaction details, or sector information are provided in the filing summary.

08-01-2026

WEBTOON Entertainment Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001997859-26-000004, Size: 144 KB), reporting Item 3.02 Unregistered Sales of Equity Securities and Item 7.01 Regulation FD Disclosure. This is a multi-item filing with no specific details on transaction values, share counts, or financial impacts provided. Item 3.02 indicates mandatory disclosure of unregistered equity sales, while Item 7.01 is a voluntary Regulation FD release.

08-01-2026

KALA BIO, Inc. filed a Form 8-K on 2026-01-08 (AccNo: 0001829126-26-000110, Size: 526 KB) disclosing entry into a Material Definitive Agreement under Item 1.01. Item 9.01 includes Financial Statements and Exhibits. No details on the agreement, transaction value, parties, or financial impacts are provided in the summary.

08-01-2026

Datavault AI Inc. filed a Form 8-K on January 08, 2026, under Item 8.01 Other Events, with Accession Number 0001104659-26-002125 and file size of 187 KB. This appears to be a single-item voluntary disclosure, as no other items or specific event details are mentioned. No financial metrics, transaction values, or strategic implications are disclosed.

08-01-2026

Ambiq Micro, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007673, Size: 143 KB), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on individuals, positions, reasons for change, compensation, or board impacts are provided. Sector is not specified.

08-01-2026

OFF THE HOOK YS INC. filed a Form 8-K on January 08, 2026 (AccNo: 0001493152-26-000968, size 221 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event, transaction details, financial metrics, or quantitative data are disclosed in the provided filing summary. Sector not specified.

08-01-2026

Netcapital Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001493152-26-000969, Size: 16 MB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, or other quantitative data disclosed in the provided summary. Sector not specified.

08-01-2026

TruBridge, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007672), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, personnel changes, disclosures, or exhibits provided in the summary. All transaction values, financial metrics, and named entities beyond the filer are NOT_DISCLOSED.

08-01-2026

TRANSUITE.ORG INC. disclosed an officer change via Form 8-K filed on January 8, 2026 (AccNo: 0001640334-26-000058, Size: 126 KB) under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons, or quantitative data provided in the filing summary. Sector not specified.

08-01-2026

General Motors Co filed a Form 8-K on January 08, 2026, under Item 8.01 Other Events. Accession number: 0001467858-26-000005; file size: 239 KB. No details on the specific event, transaction, or financial impacts are disclosed.

08-01-2026

Phathom Pharmaceuticals, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-007660, Size: 657 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. All quantitative data including transaction values, share counts, percentages, and financial metrics are NOT_DISCLOSED.

08-01-2026

Pacira BioSciences, Inc. filed a Form 8-K on 2026-01-08 (AccNo: 0001628280-26-001335, Size: 310 KB) reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure with no specific revenue, earnings, transaction values, or other quantitative metrics mentioned. Sector is not specified.

08-01-2026

Anika Therapeutics, Inc. filed a Form 8-K on 2026-01-08 (AccNo: 0001193125-26-007655, Size: 557 KB) reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation, reasons, or names are disclosed in the provided filing summary. Sector not specified.

08-01-2026

HomeTrust Bancshares, Inc. filed an 8-K on January 8, 2026, reporting under Item 8.01 Other Events. Accession Number: 0001538263-26-000002, File Size: 138 KB. No details on the specific event, transaction, or financial impacts disclosed in the provided filing summary.

08-01-2026

Realty Income Corp filed a Form 8-K on January 08, 2026 (AccNo: 0001104659-26-002136, Size: 1 MB), reporting under Items 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction values, sizes, or financial details disclosed in the provided information. Items suggest potential new debt or off-balance sheet obligations alongside equity issuances outside registration.

08-01-2026

EDUCATIONAL DEVELOPMENT CORP filed a Form 8-K on January 8, 2026 (AccNo: 0001185185-26-000075, Size: 237 KB), disclosing under Item 2.02 Results of Operations and Financial Condition, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This multi-item filing pertains to financial results in the US market. No specific financial metrics, transaction values, or other quantitative data are mentioned.

08-01-2026

Castellum, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001877939-26-000007, Size: 237 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other event, financial statements, exhibits, transaction values, or other quantitative data are provided in the filing summary. Sector is not specified.

08-01-2026

Accel Entertainment, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001698991-26-000005, Size: 157 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core event, transaction details, financial metrics, or quantitative data is disclosed in the filing summary provided. This appears to be a multi-item voluntary disclosure with no further content extracted.

08-01-2026

Kimball Electronics, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001606757-26-000004, Size: 1 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, or exhibits are provided in the filing summary. Sector not specified.

08-01-2026

Heritage Distilling Holding Company, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001788230-26-000002, Size: 185 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the Regulation FD disclosure content, core event, transaction details, financial statements, or exhibits are provided in the filing summary. Sector is not specified.

08-01-2026

Verastem, Inc. filed a Form 8-K on January 08, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). Filing details include AccNo: 0001104659-26-002135 and Size: 9 MB. Sector is not specified.

08-01-2026

Goldman Sachs Group Inc filed a Form 8-K on January 8, 2026 (AccNo: 0000886982-26-000004, Size: 3 MB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 8.01 (Other Events). This is a financial results disclosure from the US SEC. No specific financial metrics, transaction details, or numerical data provided in the filing summary.

08-01-2026

Alliant Energy Corp filed a Form 8-K on January 8, 2026 (AccNo: 0000352541-26-000003, Size: 193 KB), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on individuals, positions, reasons, or quantitative data are provided in the available information. Event type is Officer Change; sector not specified.

08-01-2026

CEMTREX INC filed an 8-K on 2026-01-08 (AccNo: 0001493152-26-000973, Size: 247 KB) disclosing under Item 2.01 the completion of an acquisition or disposition of assets, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on transaction parties, structure, value, or terms are provided in the filing summary. Sector not specified.

08-01-2026

Applied Digital Corp. filed a Form 8-K on January 08, 2026 (AccNo: 0001493152-26-000974, Size: 371 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment or resignation status, reasons, or compensation are provided. Sector is not specified.

08-01-2026

Canopy Growth Corp filed a Form 8-K on January 08, 2026 (AccNo: 0001104659-26-002134, Size: 2 MB), reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing indicating a significant transaction involving agreements, financing, and equity issuance, but core event details, transaction values, share counts, and financial impacts are NOT_DISCLOSED. No specific numbers, named counterparties, or strategic context are provided in the summary.

08-01-2026

Agenus Inc filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007706, Size: 142 KB), reporting Item 1.01 Entry into a Material Definitive Agreement and Item 3.03 Material Modifications to Rights of Security Holders. No details on the agreement, transaction terms, parties involved, financial values, or specific modifications are disclosed in the provided information. Sector not specified.

08-01-2026

Aquaron Acquisition Corp. filed an 8-K on January 8, 2026 (AccNo: 0001213900-26-002528, Size: 183 KB), disclosing under Item 1.01 entry into a Material Definitive Agreement and under Item 2.03 the creation of a Direct Financial Obligation or Obligation under an Off-Balance Sheet Arrangement, in connection with a Merger/Acquisition event. No specific details on parties involved, deal structure, valuation, consideration, or strategic rationale are provided in the filing summary. Sector is not specified.

08-01-2026

Littelfuse Inc./DE filed an 8-K on January 8, 2026 (AccNo: 0001140361-26-000720, size 194 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reason, or compensation provided in the available information. Sector not specified.

08-01-2026

Acushnet Holdings Corp. filed a Form 8-K on 2026-01-08 (AccNo: 0001672013-26-000007, Size: 501 KB) reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the agreement's nature, parties, terms, value, or financial impacts are disclosed. This is a multi-item filing for a Material Event from US SEC source; sector not specified.

08-01-2026

Graphic Packaging Holding Co filed an 8-K on January 8, 2026 (AccNo: 0001193125-26-007697, Size: 132 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). No specific details on the officer's name, position, reason for change, or any quantitative data are provided in the available information. Sector is not specified.

08-01-2026

Jamf Holding Corp. filed a Form 8-K on January 08, 2026 (AccNo: 0001104659-26-002132, Size: 202 KB), reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on the matters submitted, vote outcomes, numerical results, or other transactions are disclosed in the provided filing information.

08-01-2026

ImmuCell Corp /DE/ filed a Form 8-K on January 8, 2026 (AccNo: 0001437749-26-000885, Size: 217 KB), reporting Items 2.02 (Results of Operations and Financial Condition), 2.06 (Material Impairments), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing material impairments alongside financial results and other events. Specific details including dollar values, transaction sizes, financial metrics, or strategic context are NOT_DISCLOSED.

08-01-2026

Postal Realty Trust, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001628280-26-001352, Size: 465 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction details, or other quantitative data disclosed in the provided filing summary.

08-01-2026

Camden National Corp filed a Form 8-K on January 8, 2026 (AccNo: 0000750686-26-000004, size 170 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, or exhibits are disclosed in the provided filing summary. All quantitative financial data and core event descriptions are NOT_DISCLOSED.

08-01-2026

Tilray Brands, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001171843-26-000146, Size: 938 KB) disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction details, or quantitative data are provided in the filing summary. Sector is not specified.

08-01-2026

Greenbrier Companies Inc filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007731, size 1 MB), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. This is a financial results announcement from the US SEC. No specific financial metrics, transaction details, or quantitative data provided in the filing summary.

08-01-2026

EPLUS INC filed a Form 8-K on January 08, 2026 (AccNo: 0001022408-26-000009, Size: 168 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data are provided. Sector is not specified.

08-01-2026

Senmiao Technology Ltd filed a Form 8-K on January 8, 2026 (AccNo: 0001213900-26-002536, Size: 267 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions, individuals, reasons, or compensation provided.

08-01-2026

Vita Coco Company, Inc. filed an 8-K on January 08, 2026 (AccNo: 0001628280-26-001348, Size: 198 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer position, name, appointment/resignation status, reasons, or any quantitative data are disclosed in the provided filing summary.

08-01-2026

Uniti Group Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0000950103-26-000276, Size: 236 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. All quantitative financial metrics, transaction values, and other specifics are NOT_DISCLOSED.

08-01-2026

MID PENN BANCORP INC disclosed an officer change via Form 8-K filed on January 08, 2026 (AccNo: 0000879635-26-000007, Size: 494 KB). The filing covers Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, nature of change, reasons, or compensation are provided.

08-01-2026

V2X, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001628280-26-001359, Size: 181 KB), disclosing an Item 5.02 event related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the officer involved, nature of change (appointment or resignation), reasons, or any quantitative data are provided in the available information. Sector is not specified.

08-01-2026

Calumet, Inc. (/DE) filed Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007783, size: 410 KB), reporting Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing from the US SEC source. No specific details, transaction values, or financial metrics disclosed in the provided summary.

08-01-2026

Hillenbrand, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001140361-26-000726, Size: 167 KB), reporting under Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on proposals, vote outcomes, share counts, or results are disclosed in the provided filing summary. This is a standard disclosure for shareholder meeting results.

08-01-2026

Blackstone Real Estate Income Trust, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007776, Size: 123 KB), reporting under Item 3.02 an unregistered sale of equity securities. No specific transaction details, dollar values, share counts, or other quantitative data are disclosed in the provided filing summary. This is a single-item mandatory disclosure for such events.

08-01-2026

BION ENVIRONMENTAL TECHNOLOGIES INC filed a Form 8-K on January 08, 2026 (AccNo: 0001079973-26-000065, Size: 182 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the agreement, counterparties, financial terms, or exhibits are disclosed in the provided summary. Sector not specified.

08-01-2026

Krystal Biotech, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001711279-26-000005, Size: 4 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing classified as a General Filing from us_sec source. No specific details on the disclosure content, transaction values, or financial metrics are provided in the filing summary.

08-01-2026

VEEA INC. filed a Form 8-K on January 08, 2026 (AccNo: 0001213900-26-002557, Size: 250 KB), reporting entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits (Item 9.01). This is a multi-item mandatory filing with no specific details on the transactions, counterparties, or values disclosed in the provided information. Sector is not specified.

08-01-2026

McGraw Hill, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007781, size: 131 KB), disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details such as names, positions, reasons for change, or quantitative data are provided in the summary. Sector is not specified.

08-01-2026

Lifeway Foods, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001683168-26-000158, Size: 251 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results with attached exhibits. No specific revenue, earnings, transaction values, or other quantitative financial metrics are disclosed in the provided filing summary.

08-01-2026

MERIT MEDICAL SYSTEMS INC filed an 8-K on January 08, 2026 (AccNo: 0000856982-26-000002, Size: 292 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). Event type is Officer Change from US SEC source; sector not specified. No specific details on position, person, reason, or financial metrics provided.

08-01-2026

Navient Corp (NAVIENT) filed an 8-K on January 8, 2026 (AccNo: 0001140361-26-000724, Size: 230 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits are included. No specific details on the officer, position, appointment/resignation, reasons, or quantitative data are provided.

08-01-2026

Exodus Movement, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007775, Size: 151 KB) reporting under Item 8.01 Other Events. No details on the core event, transaction, financial impact, or other specifics are provided in the filing summary. All quantitative data, named entities beyond the filer, and material implications are NOT_DISCLOSED.

08-01-2026

Septerna, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007772, size 145 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing focused on voluntary disclosure of material information and attached exhibits. No specific details on the core event, financials, or transactions are disclosed in the provided filing summary.

08-01-2026

Beachbody Company, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-007774, Size: 1 MB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, disclosures, transaction value, or financial impacts are provided in the available summary. All quantitative financial data is NOT_DISCLOSED.

08-01-2026

SilverBox Corp V filed a Form 8-K on January 8, 2026 (AccNo: 0001104659-26-002148, size: 261 KB), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on individuals involved, positions affected, reasons for change, or any quantitative data are provided in the filing summary. Sector is not specified.

08-01-2026

McEwen Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001104659-26-002144, size: 241 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events or exhibits are disclosed in the provided filing summary. Sector is not specified.

08-01-2026

INNO HOLDINGS INC. filed a Form 8-K on January 08, 2026, reporting under Item 8.01 Other Events. The filing accession number is 0001493152-26-000980 with a size of 203 KB. No details on the specific event, transaction values, financial impacts, or other quantitative data are disclosed.

08-01-2026

urban-gro, Inc. filed a Form 8-K on 2026-01-08 (AccNo: 0001213900-26-002552, Size: 194 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No specific details on the delisting trigger, financial impacts, transaction values, or sector are disclosed. This represents a material compliance event with bearish implications for liquidity and valuation.

08-01-2026

Art Technology Acquisition Corp. filed an 8-K on January 8, 2026 (AccNo: 0001213900-26-002553, Size: 1 MB) disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), departures/elections of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation/bylaws or fiscal year change (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). This filing indicates a merger/acquisition event for the SPAC-like entity, but specific parties, deal structure, valuation, and terms are NOT_DISCLOSED. Sector not specified.

08-01-2026

Loop Industries, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001437749-26-000892, Size: 311 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected officer position (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or any quantitative data are disclosed. Sector is not specified.

08-01-2026

Quanterix Corp filed an 8-K on January 08, 2026 (AccNo: 0001628280-26-001369, Size: 350 KB) disclosing an officer change under Item 5.02, alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the officer position, appointment/resignation, reasons, or financial metrics are provided in the filing summary. Sector not specified.

08-01-2026

KalVista Pharmaceuticals, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007801, Size: 2 MB), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a financial results disclosure for a US biotech company, but specific revenue, earnings, or other metrics are NOT_DISCLOSED. Sector is not specified.

08-01-2026

Planet 13 Holdings Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001437749-26-000891, Size: 150 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any compensation arrangements are provided in the filing summary. Sector is not specified.

08-01-2026

DIGITAL ALLY, INC. filed a Form 8-K on January 08, 2026 (AccNo: 0001493152-26-000981, Size: 660 KB), reporting under Item 5.03 amendments to Articles of Incorporation or Bylaws or a change in fiscal year, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the nature of amendments, events, or exhibits are disclosed in the provided filing summary. Sector is not specified.

08-01-2026

Illumina, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001110803-26-000006, Size: 185 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, or any quantitative data provided in the filing summary. Sector not specified.

08-01-2026

American Well Corp filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007807, Size: 918 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. The core event is the entry into this unspecified Material Definitive Agreement. No transaction values, financial impacts, named entities, or other quantitative details are disclosed in the provided filing summary.

08-01-2026

Praxis Precision Medicines, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001689548-26-000005, Size: 155 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Event type is Officer Change from US SEC source. Sector not specified; no details on specific officer, position, reason, or nature of change provided.

08-01-2026

ADC Therapeutics SA filed an 8-K on January 08, 2026 (AccNo: 0001628280-26-001386), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure). This is a financial results disclosure for a company in an unspecified sector. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary.

08-01-2026

INTELLIGENT BIO SOLUTIONS INC. filed a Form 8-K on January 08, 2026 (AccNo: 0001493152-26-000984, Size: 202 KB) under Item 8.01 Other Events. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary. Sector not specified.

08-01-2026

CONMED Corp filed an 8-K on 2026-01-08 (AccNo: 0001174947-26-000017, Size: 284 KB) disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 lists financial statements and exhibits. No specific details on the officer change, names, positions, reasons, or quantitative data provided.

08-01-2026

Aehr Test Systems filed a Form 8-K on January 08, 2026 (AccNo: 0001654954-26-000197, Size: 473 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a financial results disclosure from the US SEC for an unspecified sector. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary.

08-01-2026

SS Innovations International, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001213900-26-002572, Size: 311 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the summary. Sector is not specified.

08-01-2026

Ensysce Biosciences, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001493152-26-000994, Size: 214 KB) reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on the matters submitted, voting results, or outcomes are disclosed in the provided filing summary. This appears to be a standard mandatory disclosure following a shareholder meeting.

08-01-2026

Clearway Energy, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001104659-26-002190, Size: 281 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, transaction values, financial impacts, or other quantitative data are disclosed in the provided filing summary. Sector is not specified.

08-01-2026

Janus International Group, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001104659-26-002199, Size: 918 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, disclosures, or exhibits provided in the summary. Sector not specified.

08-01-2026

VolitionRx Ltd filed a Form 8-K on January 8, 2026 (AccNo: 0001477932-26-000107, size 737 KB), reporting entry into a material definitive agreement (Item 1.01) and unregistered sales of equity securities (Item 3.02), with exhibits under Item 9.01. This is a multi-item mandatory filing with no specific transaction details, dollar values, or financial impacts disclosed in the provided summary. Sector not specified.

08-01-2026

GameStop Corp. filed a Form 8-K on January 08, 2026 (AccNo: 0001326380-26-000007, Size: 392 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other events or the nature of the financial statements/exhibits are provided in the filing summary. All transaction details, financial metrics, and named entities beyond the filer are NOT_DISCLOSED.

08-01-2026

Indaptus Therapeutics, Inc. filed an 8-K on 2026-01-08 (AccNo: 0001493152-26-001004, Size: 207 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. Item 9.01 references financial statements and exhibits. No specific details on positions, individuals, reasons, or quantitative data provided.

08-01-2026

Amphenol Corp (/DE/) filed a Form 8-K on January 8, 2026 (AccNo: 0001104659-26-002183, Size: 205 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, internal/external status, or quantitative data such as compensation are provided in the summary. Event type is Officer Change; sector not specified.

08-01-2026

FG Nexus Inc. disclosed the completion of an acquisition or disposition of assets in an 8-K filing on January 08, 2026 (AccNo: 0001493152-26-001002, Size: 250 KB) under Item 2.01. No details on parties involved, deal structure, valuation, or strategic rationale are provided in the filing summary. Sector is not specified.

08-01-2026

Gabelli Dividend & Income Trust filed a Form 8-K on January 8, 2026 (AccNo: 0001829126-26-000118, Size: 242 KB) under Item 8.01 Other Events announcing a dividend. No specific details on dividend amount, record date, ex-dividend date, payment timeline, or eligibility are disclosed. Sector is not specified.

08-01-2026

Wellgistics Health, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001493152-26-001001, size: 940 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, or quantitative data disclosed in the provided information. Sector not specified.

08-01-2026

374Water Inc. filed an 8-K on January 8, 2026 (AccNo: 0001654954-26-000199, Size: 142 KB) disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, appointment/resignation status, reasons, or any financial metrics are disclosed. Sector is not specified.

08-01-2026

Guidewire Software, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001528396-26-000007, Size: 157 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. This is a general filing with limited metadata available.

08-01-2026

Sera Prognostics, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-007850, Size: 16 MB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event details, transaction values, financial metrics, or other quantitative data are explicitly stated in the provided filing summary. All specific impacts remain NOT_DISCLOSED.